Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
386M
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
5.4M
-
Shares change
-
-532K
-
Total reported value, excl. options
-
$20.3M
-
Value change
-
-$2M
-
Put/Call ratio
-
0.89
-
Number of buys
-
12
-
Number of sells
-
-14
-
Price
-
$3.76
Significant Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q1 2021
37 filings reported holding TRIB - Trinity Biotech plc - Class 'A' Ordinary Shares as of Q1 2021.
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.4M shares
of 386M outstanding shares and own 1.4% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (1.84M shares), HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC (1.64M shares), ACADIAN ASSET MANAGEMENT LLC (753K shares), STONEHILL CAPITAL MANAGEMENT LLC (489K shares), MORGAN STANLEY (111K shares), MARSHALL WACE, LLP (90.7K shares), Navellier & Associates Inc (81.7K shares), MILLENNIUM MANAGEMENT LLC (59K shares), TWO SIGMA INVESTMENTS, LP (39.3K shares), and Squarepoint Ops LLC (36.5K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.